The Largest Insurance Expansion in History

That is the title of an important paper by Jonathan Gruber, Mengyun Lin & Junjian Yi. The abstract is below: The New Cooperative Medical Scheme (NCMS) rolled out in China from 2003-2008 provided insurance to 800 million rural Chinese. We combine aggregate mortality data with individual survey data, and identify the impact of the NCMS…

Specialty drug coverage: medical vs. pharmacy benefit

Historically, physician administered specialty pharmaceuticals are covered by a patient’s medical benefit and oral medications are covered by the pharmacy benefit. Increasingly, however, specialty pharmaceuticals are being covered by pharmaceutical benefit. Does this make a difference? Does medical vs. pharmacy coverage of drugs impact patient access? A recent paper by Levine et al. (2023) aims…

Insurance Obstacles in America

As reported based on a N.Y. Times/KFF survey: A majority of Americans with health insurance said they had encountered obstacles to coverage, including denied medical care, higher bills and a dearth of doctors in their plans… About 40 percent of those surveyed said they had delayed or gone without care in the last year because…

20% of US GDP to be spent on health care

That is the conclusion from the Centers for Medicare and Medicaid Services National Health Expenditure Projections. The paper–published in Health Affairs—summarizes the spending changes as follows: National health expenditures are projected to grow 5.4 percent, on average, over the course of 2022–31 and to account for roughly 20 percent of the economy by the end of that…

CBO projections of US health insurance coverage: 2023-2033

A paper by Hanson et al. (2023) summarizes the Congressional Budget Office’s projections around US health insurance coverage between 2023-2033. They find that low rates of uninsurance due to provisions enacted to combat COVID-19 will not be sustained as these provisions expire: Temporary policies enacted in response to the COVID-19 pandemic have increased Medicaid and…

Impact of the public option in Minnesota

A Minnesota bill would expand the MinnesotaCare Medicaid system to incorproate a public option. The public option would reduce uninsurance rates, but would also have some negative impacts on providers. An FTI report (“Evaluating the Potential Impact of a Public Option on Minnesota’s Hospitals and Patients“) reviews the implications of the public option in Minnesota.…

Payer perceptions of value frameworks

A paper by Westrich et al. (2023) examines payer perceptions of five different value frameworks. Value frameworks of interest included: American Society of Clinical Oncology (ASCO) Value Framework, Drug Pricing Lab’s Drug Abacus (formerly Memorial Sloan Kettering Cancer Center’s Drug Abacus), Institute for Clinical and Economic Review (ICER) value assessment framework and evidence reports The…